Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9385)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 28, 2018 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Atsawarungruangkit A, Chenbhanich J, Dickstein G. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population. World J Gastroenterol 2018; 24(32): 3663-3670 [PMID: 30166861 DOI: 10.3748/wjg.v24.i32.3663] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i32/3663.htm |
| Number | Citing Articles |
| 1 |
Amporn Atsawarungruangkit, Passisd Laoveeravat, Kittichai Promrat. Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database. World Journal of Hepatology 2021; 13(10): 1417-1427 doi: 10.4254/wjh.v13.i10.1417
|
| 2 |
Chrysoula Boutari, Konstantinos Stefanakis, Stamatia Simati, Valentina Guatibonza-García, Laura Valenzuela-Vallejo, Ioanna A. Anastasiou, Margery A. Connelly, Alexander Kokkinos, Christos S. Mantzoros. Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02264-5
|
| 3 |
Asieh Mansour, Mohammad Reza Mohajeri-Tehrani, Majid Samadi, Hadis Gerami, Mostafa Qorbani, Nick Bellissimo, Hossein Poustchi, Azita Hekmatdoost. Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients. Acta Diabetologica 2019; 56(11): 1199 doi: 10.1007/s00592-019-01374-x
|
| 4 |
Seda Turgut, Didem Acarer, Hakan Seyit, Naim Pamuk, Hamide Piskinpasa, Evin Bozkur, Mehmet Karabulut, Ilkay Cakir. Insulin-Like Growth Factor-I Might be a Predictor for Severe
Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients. Hormone and Metabolic Research 2022; 54(10): 696 doi: 10.1055/a-1856-7014
|
| 5 |
Mark D. Muthiah, Arun J. Sanyal. Burden of Disease due to Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2020; 49(1): 1 doi: 10.1016/j.gtc.2019.09.007
|
| 6 |
Xinyuan Zhang, Longgang Zhao, Cami N. Christopher, Fred K. Tabung, Wei Bao, David O. Garcia, Aladdin H. Shadyab, Nazmus Saquib, Marian L. Neuhouser, Lesley F. Tinker, Xuehong Zhang. Association of dietary insulinemic and inflammatory potential with risk of liver cancer and chronic liver disease mortality in postmenopausal women: a prospective cohort study. The American Journal of Clinical Nutrition 2023; 118(3): 530 doi: 10.1016/j.ajcnut.2023.07.009
|
| 7 |
Kavita Garg, Scott Brackett, Irl B. Hirsch, Satish K. Garg. NAFLD/NASH and Diabetes. Diabetes Technology & Therapeutics 2020; 22(S1): S-174 doi: 10.1089/dia.2020.2513
|
| 8 |
Qiumei Zhou, Yulong Wang, Jiajia Wang, Yating Liu, Dehui Qi, Wei Yao, Hui Jiang, Tingting Li, Kaiquan Huang, Wancun Zhang, Xingxing Huo. Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Medicine 2021; 100(10): e24940 doi: 10.1097/MD.0000000000024940
|
| 9 |
Laurinda Adusu‐Donkor, Emmanuel Kwaku Ofori, Fleischer C. N. Kotey, Francis Kwaku Dogodzi, Wormenor Dziedzorm, Alfred Buabeng, Segla Kwame Bernard, Seth K. Amponsah, Henry Asare‐Anane. Blood C‐peptide concentration as a proxy marker of cardiovascular disease: An observational cross‐sectional study. Health Science Reports 2023; 6(9) doi: 10.1002/hsr2.1535
|
| 10 |
Mohamed Hany, Hala M Demerdash, Anwar Ashraf Abouelnasr, Bart Torensma. Effect of Cytokeratin-18, C-peptide, MHR, and MACK-3 Biomarkers in Metabolic Dysfunction-Associated Fatty Liver Disease After Laparoscopic Sleeve Gastrectomy. Biomarker Insights 2024; 19 doi: 10.1177/11772719241256496
|
| 11 |
Hanying Liu, Xiao Li, Xiaodong Han, Yan Zhang, Yanting Gu, Lianjie Sun, Junfeng Han, Yinfang Tu, Yuqian Bao, Wenkun Bai, Haoyong Yu. Simple surrogate equations to predict controlled attenuation parameter values for screening non-alcoholic fatty liver disease in a Chinese population. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.894895
|
| 12 |
Mohammad Hassan Sohouli, Ali Akbar Sayyari, Abolfazl Lari, Ghazaleh Nameni, Mojtaba Lotfi, Somaye Fatahi, Solaleh Saneie, Mihnea‐Alexandru Găman, Farzan Moodi, Pourya Raee, Shahin Aghamiri, Appaji Rayi, Ali Shahriari, Vihan Moodi. Association of dietary insulinaemic potential and odds of non‐alcoholic fatty liver disease among adults: A case–control study. Journal of Human Nutrition and Dietetics 2021; 34(5): 901 doi: 10.1111/jhn.12865
|
| 13 |
Zahra Jamalizadeh Bahaabadi, Prashant Kesharwani, Amirhossein Sahebkar. Detecting C-peptide using biosensors for diagnosis and monitoring of disease. Microchemical Journal 2024; 207: 111922 doi: 10.1016/j.microc.2024.111922
|
| 14 |
Fatma DEMİRBAŞ, Gönül DİNLER ÇALTEPE, Atakan COMBA, Hasan ABBASGULİYEV, Ayhan Gazi KALAYCI. Evaluation of the relationship between non-alcoholic fatty liver disease and serum c-peptide, c-peptide to glucose and c-peptide to HbA1C ratio in obese children. Journal of Surgery and Medicine 2020; 4(12): 1128 doi: 10.28982/josam.778883
|
| 15 |
Ningjian Wang, Yuying Wang, Wen Zhang, Yi Chen, Xiaoman Chen, Chiyu Wang, Qing Li, Chi Chen, Boren Jiang, Yingli Lu. C‐peptide is associated with NAFLD inflammatory and fibrotic progression in type 2 diabetes. Diabetes/Metabolism Research and Reviews 2020; 36(2) doi: 10.1002/dmrr.3210
|
| 16 |
Khushdeep Bandesh, Muneesh Pal, Abitha Balakrishnan, Pradeep Gautam, Punam Jha, Nikhil Tandon, Beena Pillai, Dwaipayan Bharadwaj. A novel antisense lncRNA, ARBAG harboring an RNA destabilizing GWAS variant for C-peptide dictates the transcript isoforms of GABRA6 in cerebellum. Human Molecular Genetics 2023; 32(19): 2929 doi: 10.1093/hmg/ddad119
|
| 17 |
Hui‐Huan Luo, Meng‐Di Zhao, Xiao‐Fei Feng, Xiao‐Qian Gao, Mo Hong, Ming‐Li Liu, Yan‐Ping Li, Wan‐Qiu Liu, Yu‐Mo Liu, Cheng‐Cheng Yu, Yun‐Feng Cao, Xi‐Lin Yang, Zhong‐Ze Fang, Ping Zhang. Decreased plasma n6 : n3 polyunsaturated fatty acids ratio interacting with high C‐peptide promotes non‐alcoholic fatty liver disease in type 2 diabetes patients. Journal of Diabetes Investigation 2021; 12(7): 1263 doi: 10.1111/jdi.13469
|
| 18 |
Chifa Ma, Yiwen Liu, Shuli He, Jingbo Zeng, Pingping Li, Chunxiao Ma, Fan Ping, Huabing Zhang, Lingling Xu, Wei Li, Yuxiu Li. C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.600472
|
| 19 |
Enfa Zhao, Shimin Chen. Association of serum C-peptide with all-cause and cardiovascular disease mortality in ultrasound-defined nonalcoholic fatty liver disease. Clinics and Research in Hepatology and Gastroenterology 2022; 46(10): 102002 doi: 10.1016/j.clinre.2022.102002
|
| 20 |
Yujuan Zhang, Liulan Xiang, Fang Qi, Yutian Cao, Wenhui Zhang, Tiansu Lv, Xiqiao Zhou. The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1322563
|
| 21 |
雅静 黄. C-Peptide and Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes. Advances in Clinical Medicine 2021; 11(04): 1649 doi: 10.12677/ACM.2021.114237
|
| 22 |
Rou Shi, Chunwen Lin, Yaping Hong, Xiaoying Xia, Yingjian Chen, Shu Li, Liangchang Xiu, Zhenbo Xu. Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus Patients. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/8868339
|